Characterization of neovascular age-related macular degeneration patients with outer retinal tubulations

Ophthalmologica

Volumn 229, Issue 3, 2013, Pages 147-151

  Faria Correia, F ^a,c   Barros Pereira, R ^a,b   Queiros Mendanha L ^a   Fonseca, S ^a   Mendonca L ^a   Falcao M S ^a,b   Brandao E ^a   Falcao Reis F ^a,b   Carneiro, A M ^a,b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b University of Porto   (Portugal)

^c NONE   (Portugal)

Author keywords

Neovascular age related macular degeneration; Outer retinal tubulations; Spectral domain optical coherence tomography

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; RANIBIZUMAB;

AGED; ANTIANGIOGENIC THERAPY; ARTICLE; CONTROLLED STUDY; EYE EXAMINATION; FIBROSIS; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; OUTER RETINAL TUBULATION; RETINA ANGIOGRAPHY; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; AGE RELATED MACULAR DEGENERATION; CLINICAL ARTICLE; NEOVASCULAR AGE RELATED MACULAR DEGENERATION; OPHTHALMOSCOPY; PHOTORECEPTOR; RETINA FOVEA; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY;

AGED; ANGIOGENESIS INHIBITORS; EXUDATES AND TRANSUDATES; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAVITREAL INJECTIONS; MALE; RETINAL NEURONS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84876477524     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000346854     Document Type: Article

References (16)

1. Resnikoff S, Pascolini D, Etya'ale D, et al: Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82:844-851. (Pubitemid 39573742)
2. Rosenfeld PJ: Bevacizumab versus ranibi-zumab for AMD. N Engl J Med 2011; 364: 1966-1967.
3. Mitchell P, Korobelnik JF, Lanzetta P, et al: Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol 2010; 94:2-13.
4. Martin DF, Maguire MG, Ying GS, et al: Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011; 364:1897-1908.
5. Cukras C, Wang YD, Meyerle CB, et al: Optical coherence tomography-based decision making in exudative age-related macular degeneration: comparison of time-vs. spectral-domain devices. Eye (Lond) 2010; 24:775-783.
6. Fung AE, Lalwani GA, Rosenfeld PJ, et al: An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibi-zumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007; 143:566-583.
7. Lalwani GA, Rosenfeld PJ, Fung AE, et al: A variable-dosing regimen with intravitreal ra-nibizumab for neovascular age-related macu-lar degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 2009; 148:43-58.
8. Forte R, Cennamo GL, Finelli ML, et al: Comparison of time domain Stratus OCT and spectral domain SLO/OCT for assessment of macular thickness and volume. Eye 2009; 23: 2071-2078.
9. Sayanagi K, Sharma S, Yamamoto T, et al: Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab. Ophthalmology 2009; 116:947-955.
10. Zweifel SA, Engelbert M, Laud K, et al: Outer retinal tubulation: a novel optical coherence tomography finding Arch Ophthalmol 2009; 127: 1596-1602.
11. Spaide RF, Curcio CA: Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina 2011; 31:1609-1619.
12. Hayashi H, Yamashiro K, Tsujikawa A, et al: Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. Am J Ophthalmol 2009; 148:83-89.
13. Oishi A, Hata M, Shimozono M, et al: The significance of external limiting membrane status for visual acuity in age-related macular degeneration. Curr Opin Ophthalmol 2010; 150:27-32.
14. Gass JD: Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. St Louis, Mosby, 1997, p 1067.
15. Grossniklaus HE, Gass JD: Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. Am J Ophthalmol 1998;126: 59-69. (Pubitemid 28341219)
16. Grossniklaus HE, Green WR: Choroidal neo-vascularization. Am J Ophthalmol 2004;137: 496-503.